1.
Results of the betaxolol versus placebo treatment trial in ocular hypertension.
Kamal Deborah, Garway-Heath David, Ruben Simon, O'Sullivan Fiona, Bunce Catey, Viswanathan Anath et al.
Graefes Arch Clin Exp OphthalmolMar 200331 citationsRandomized Controlled Trial
This study found betaxolol lowered IOP in ocular hypertension but did not significantly prevent conversion to glaucoma compared to placebo, suggesting limited clinical benefit for prevention.